The Foxp3+ regulatory T cell: A jack of all trades, master of regulation

Nature Immunology

Volumn 9, Issue 3, 2008, Pages 239-244

  Tang, Qizhi ^a   Bluestone, Jeffrey A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; CD39 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GALECTIN; HEME OXYGENASE 1; INTERLEUKIN 10; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; AUTOIMMUNE DISEASE; CELL INTERACTION; CELLULAR DISTRIBUTION; CELLULAR IMMUNITY; EFFECTOR CELL; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; INFECTION RESISTANCE; LYMPHOCYTE FUNCTION; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; SUPPRESSOR CELL; TUMOR IMMUNITY;

ANIMALS; ANTIGENS, SURFACE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; MODELS, IMMUNOLOGICAL; T-LYMPHOCYTES, REGULATORY;

EID: 39449126502     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni1572     Document Type: Review

References (84)

1. Gershon, R.K. & Kondo, K. Cell interactions in the induction of tolerance: The role of thymic lymphocytes. Immunology 18, 723-767 (1970).
2. Benacerraf, B., Kapp, J.A., Debre, P., Pierce, C.W. & de la Croix, F. The stimulation of specific suppressor T cells in genetic non-responder mice by linear random copolymers of L-amino acids. Transplant. Rev. 26, 21-38 (1975).
3. Bach, J.F., Boitard, C., Yasunami, R. & Dardenne, M. Control of diabetes in NOD mice by suppressor cells. J. Autoimmun. 3 Suppl. 1, 97-100 (1990).
4. Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M. & Toda, M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155, 1151-1164 (1995).
5. + thymocytes expressing L-selectin mediate "active tolerance" in the nonobase diabetic mouse. J. Immunol. 161, 2620-2628 (1998).
6. + suppressor cell and its mechanisms of action. J. Exp. Med. 171 141-157 (1990).
7. Hori, S., Nomura, T. & Sakaguchi, S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299, 1057-1061 (2003).
8. + regulatory T cells. Nat. Immunol. 4, 330-336 (2003).
9. + T regulatory cells. Nat. Immunol. 4, 337-342 (2003).
10. Roncarolo, M.G. et al. Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol. Rev. 212, 28-50 (2006).
11. Faria, A.M. & Weiner, H.L. Oral tolerance. Immunol. Rev. 206 232-259 (2005).
12. s cells: the crucial role of inhibitory receptors ILT3 and ILT4. Nat. Immunol. 3, 237-243 (2002).
13. Kronenberg, M. Toward an understanding of NKT cell biology: Progress and paradoxes. Annu. Rev. Immunol. 23, 877-900 (2005).
14. Zhang, Z.X., Yang, L., Young, K.J., DuTemple, B. & Zhang, L. Identification of a previously unknown antigen-specific regulatory T cell and its mechanism of suppression. Nat. Med. 6, 782-789 (2000).
15. Hayday, A. & Tigelaar, R. Immunoregulation in the tissues by γδ T cells. Nat. Rev. Immunol. 3, 233-242 (2003).
16. Bluestone, J.A. & Abbas, A.K. Natural versus adaptive regulatory T cells. Nat. Rev. Immunol. 3, 253-257 (2003).
17. Malek, T.R., Yu, A., Vincek, V., Scibelli, P. & Kong, L. CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rβ-deficient mice. Implications for the nonredundant function of IL-2. Immunity 17 167-178 (2002).
18. Kim, J.M., Rasmussen, J.P. & Rudensky, A.Y. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat. Immunol. 8, 191-197 (2007).
19. Gambineri, E., Torgerson, T.R. & Ochs, H.D. Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis. Curr. Opin. Rheumatol. 15, 430-435 (2003).
20. + regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 22, 531-562 (2004).
21. Qin, S. et al. "Infectious" transplantation tolerance. Science 259, 974-977 (1993).
22. + regulatory T cells restore normoglycemia in diabetic NOD mice. J. Exp. Med. 204, 191-201 (2007).
23. Mempel, T.R. et al. Regulatory T. cells reversibly suppress cytotoxic T cell function independent of effector differentiation. Immunity 25, 129-141 (2006).
24. + immunoregulatory cells. J. Immunol. 167, 1137-1140 (2001).
25. Bopp, T. et al. Cyclic adenosine monophosphate is a key component of regulatory T cell-mediated suppression. J. Exp. Med. 204, 1303-1310 (2007).
26. Grossman, W.J. et al. Human T regulatory cells can use the perforin pathway to cause autologous target cell death. Immunity 21, 589-601 (2004).
27. + regulatory cells involves a granzyme B-dependent, perforin-independent mechanism. J. Immunol. 174, 1783-1786 (2005).
28. + T cells selectively kill B lymphocytes. Blood 107 3925-3932 (2006).
29. Qin, H.Y. et al. A novel mechanism of regulatory T cell-mediated down-regulation of autoimmunity. Int. Immunol. 18, 1001-1015 (2006).
30. Teng, Q. et al. Visualizing regulatory T cell control of autoimmune responses in non-obese diabetic mice. Nat. Immunol. 7, 83-92 (2006).
31. Tang, Q. & Krummel, M.F. Imaging the function of regulatory T cells in vivo. Curr. Opin. Immunol. 18, 496-502 (2006).
32. + T cells. Nat. Immunol. 8, 1353-1362 (2007).
33. Valenzuela, H.F. et al. O-glycosylation regulates LNCaP prostate cancer cell susceptibility to apoptosis induced by galectin-1. Cancer Res. 67, 6155-6162 (2007).
34. H-17 effector cells selectively regulates susceptibility to cell death. Nat. Immunol., 8, 825-834 (2007).
35. + T helper cells. J. Exp. Med. 196, 255-260 (2002).
36. + regulatory contact-dependent T cells induce interleukin 10-producing, contact-independent type 1-like regulatory T cells. J. Exp. Med. 196, 247-253 (2002).
37. + regulatory T cells is interleukin 10 dependent. J. Exp. Med. 202, 1539-1547 (2005).
38. Munn, D.H. & Mellor, A.L. IDO and tolerance to tumors. Trends Mol. Med. 10, 15-18 (2004).
39. Mellor, A.L. & Munn, D. Policing pregnancy: Tregs help keep the peace. Trends Immunol. 25, 563-565 (2004).
40. Puccetti, P. & Grohmann, U. IDO and regulatory T cells: A role for reverse signalling and non-canonical NF-κB activation. Nat. Rev. Immunol. 7, 817-823 (2007).
41. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188, 287-296 (1998).
42. + regulatory T cell function. Eur. J. Immunol. 34, 2996-3006 (2004).
43. + regulatory T cells abrogates their function in vivo. J. Immunol. 177, 4376-4383 (2006).
44. Chikuma, S. & Bluestone, J.A. Expression of CTLA-4 and FOXP3 in cis protects from lethal lymphoproliferative disease. Eur. J. Immunol. 37, 1285-1289 (2007).
45. 8 on dendritic cells causes autoimmunity and colitis in mice. Nature 449, 361-365 (2007).
46. Pesu, M., Muul, L., Kanno, Y. & O'Shea, J.J. Proprotein convertase furin is preferentially expressed in T helper 1 cells and regulates interferon γ. Blood 108, 983-985 (2006).
47. + regulatory T cells via a TGF-β and retinoic acid-dependent mechanism. J. Exp. Med. 204, 1757-1764 (2007).
48. + naturally anergic and suppressive T cells: Induction of autoimmune disease by breaking their anergic/suppressive state. Int. Immunol. 10, 1999-1980 (1998).
49. + regulatory T cells is mediated by cell surface-bound transforming growth factor β. J. Exp. Med. 194 629-644 (2001).
50. You, S., Thieblemont, N., Alyanakian, M.A., Bach, J.F. & Chatenoud. L. Transforming growth factor-β and T-cell-mediated immunoregulation in the control of autoimmune diabetes. Immunol. Rev. 212, 185-202 (2006).
51. + regulatory T cells control Leishmania major persistence and immunity. Nature 420, 502-507(2002).
52. R cells suppress innate immune pathology through cytokine-dependent mechanisms. J. Exp. Med. 197, 111-119 (2003).
53. Li, M.O., Wan, Y.Y. & Flavell, R.A. T cell-produced transforming growth factor-β1 controls T cell tolerance and regulates Th1- and -Th17-cell differentiation. Immunity 26, 579-591 (2007).
54. Wilson, M.S. et al. Suppression of allergic airway inflammation by helminth-induced regulatory T cells. J. Exp. Med. 202, 1199-1212 (2005).
55. + regulatory 'T cells is not essential for suppression of intestinal inflammation. Eur. J. Immunol. 35, 2886-2895 (2005).
56. Choi, B.M., Pae, H.O., Jeong,Y.R., Kim, Y.M. Chung,, H.T. Critical role of heme oxygenase-1 in Foxp3-mediated immune suppression. Biochem. Biophys. Res. Commun. 327, 1066-1071 (2005).
57. high regulatory T cells suppress allergic airway inflammation. J. Immunol. 177, 5936-5945 (2006).
58. Deaglio, S. et al. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J. Exp. Med. 204, 1257-1265 (2007).
59. regulatory T cells: Preteome, analysis identifies galectin-10 as a novel marker essential for their anergy and suppressive function. Blood 110, 1550-1558 (2007).
60. + T cells. Blood 109, 2058-2065 (2007).
61. Terness, P. et al. Tolerance signaling molecules and pregnancy: IDO, galectins, and the renaissance of regulatory T cells. Am. J. Reprod. Immunol. 58, 238-254 (2007).
62. Collison, L.W. et al. The inhibitory cytokine IL-35 contribute to regulatory T-cell function. Nature 450, 566-569 (2007).
63. Izcue, A., Coombes, T.L. & Powrie, F. Regulatory T cells suppresss systemic and mucosal immune activation to control intestinal inflammation. Immunol. Rev. 212, 256-271 (2006).
64. Belkaid, Y., Blank, R.B. & Suffia, I. Natural regulatory T cells and parasites: A common quest for host homeostasis. Immunol. Rev. 212, 287-300 (2006).
65. ++ T cells secreting interleukin-10 and transforming growth factor-β1 mediates suppression in the tumor microenvironment. Clin. Cancer Res. 13, 4345-4354 (2007).
66. + T cell receptors. Immunity 21, 267-277 (2004).
67. + regulatory T cells induced by an agonist self-peptide. Nat. Immunol. 2, 301-306 (2001).
68. Waterhouse, P. et al. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 270, 985-988 (1995).
69. Shull, M. M. et al. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature 359, 693-699 (1992).
70. + T cell-mediated suppression by dendritic cells. Science 299, 1033-1036 (2003).
71. Balasa, B., Van Gunst, K., Jung, N., Katz, J.D. & Sarvetnick, N. IL-10 deficiency does not inhibit insulitis and accelerates cyclophosphamide-induced diabetes in the nonobese diabetic mouse. Cell. Immunol. 202, 97-102 (2000).
72. + T cells. J. Autoimmun. 16, 115-123 (2001).
73. Hara M. et al. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J. Immunol. 166: 3789-3796 (2001).
74. + T cells through TGF-β-TGF-β receptor interactions in typee 1 diabetes. Proc. Natl. Acad. Sci. USA 100, 10878-10883 (2003).
75. Belghith, M. et. al. TGF-β-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes. Nat. Med. 9, 1202-1208 (2003).
76. + regulatory T cells can mediate suppressor function in the absence of transforming growth factor β1 production and responsiveness. J. Exp. Med. 196, 237-246 (2002).
77. + regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. 192, 303-310 (2000).
78. Salomon, B. & Bluestone, J.A. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu. Rev. Immunol. 19: 225-252 (2001).
79. + regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses. J. Immunol. 168, 1080-1086 (2002).
80. Cao, X. et al. Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance. Immunity 27, 635-646 (2007).
81. Sawitzki, B. et al. IFN-γ production by alloantigen-reactive regulatory T-cells is important for their regulatory function in vivo. J. Exp. Med. 201, 1925-1935 (2005).
82. Lu, L.F. et al. Mast cells are essential intermediaries in regulatory T-cell tolerance. Nature 442, 997-1002 (2006).
83. Zelenay, S., Chora, A., Soares, M.P. & Demengeot, J. Heme oxygenase-1 is not required for mouse regulatory T cell development and function. Int. Immunol. 10, 11-18 (2007).
84. Sato, K. et al. Carbon monoxide-generated by heme oxygenase-1 suppresses the rejection mouse-to-rat cardiac transplants. J. Immunol. 166, 4185-4194 (2001).